13F HOLDINGS REPORT (Amended)
Stonepine Capital Management, LLC
Quarter ended Q2 2024 · Filed August 21, 2024 · Accession 0000935836-24-000540
Total Value
$109.6M
Positions
25
Other Managers
0
Confidential Omitted
No
Holdings (25)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ADMA BIOLOGICS INC | ADMA | 1,870,000 | $20.9M | 19.07% |
| 2 | ALIMERA SCIENCES INC | 016259202 | 3,511,816 | $19.5M | 17.81% |
| 3 | EVOLUS INC | EOLS | 1,657,611 | $18.0M | 16.41% |
| 4 | GALAPAGOS NV-SPON ADR | GLPGF | 485,000 | $12.0M | 10.97% |
| 5 | REVANCE THERAPEUTICS INC | 761330109 | 2,800,000 | $7.2M | 6.57% |
| 6 | XOMA CORP | XOMAP | 250,129 | $5.9M | 5.41% |
| 7 | ANIKA THERAPEUTICS INC | ANIK | 165,397 | $4.2M | 3.82% |
| 8 | TELA BIO INC | TELA | 625,645 | $2.9M | 2.68% |
| 9 | RIGEL PHARMACEUTICALS INC | RIGL | 305,000 | $2.5M | 2.29% |
| 10 | OPTINOSE INC | 68404V100 | 2,350,010 | $2.4M | 2.23% |
| 11 | ACLARIS THERAPEUTICS INC | ACRS | 1,927,446 | $2.1M | 1.93% |
| 12 | SCPHARMACEUTICALS INC | 810648105 | 421,703 | $1.8M | 1.67% |
| 13 | AURINIA PHARMACEUTICALS INC | AUPH | 300,000 | $1.7M | 1.56% |
| 14 | MILESTONE PHARMACEUTICALS IN | MIST | 1,239,199 | $1.6M | 1.49% |
| 15 | AYTU BIOPHARMA INC | AYTU | 472,469 | $1.4M | 1.26% |
| 16 | KIORA PHARMACEUTICALS INC | KPHMW | 200,000 | $840,000 | 0.77% |
| 17 | ADICET BIO INC | ACET | 609,446 | $737,430 | 0.67% |
| 18 | SURROZEN INC | SRZNW | 66,084 | $723,620 | 0.66% |
| 19 | EXAGEN INC | XGN | 358,697 | $652,829 | 0.60% |
| 20 | KEZAR LIFE SCIENCES INC | KZR | 1,050,452 | $630,271 | 0.58% |
| 21 | APREA THERAPEUTICS INC | APRE | 137,174 | $558,298 | 0.51% |
| 22 | 2SEVENTY BIO INC | 901384107 | 100,000 | $385,000 | 0.35% |
| 23 | ETON PHARMACEUTICALS INC | ETON | 110,000 | $361,900 | 0.33% |
| 24 | IRONWOOD PHARMACEUTICALS INC | IRWD | 48,012 | $313,038 | 0.29% |
| 25 | ACADIA PHARMACEUTICALS INC | ACAD | 5,000 | $81,250 | 0.07% |